Medical diagnostics technology developer Nanosonics (ASX:NAN) has warned that it has become aware of a substandard component being used in the production of its Tryphon EPR ultrasound disinfectant device.
The sub-assembly component is being developed by an external overseas vendor, which has already agreed to update the components in the near-term, Nanosonics said.
The company added that it is also searching for replacement components from alternate vendors.
The substandard component does nothing to prevent the Trophon EPR from meeting its full performance standards, including safety and efficiency, Nanosonics said, and the procurement of replacement components would scale up production efficiency and reliability.
Join the CIO Australia group on LinkedIn. The group is open to CIOs, IT Directors, COOs, CTOs and senior IT managers.